Squarepoint
CVRS

Squarepoint’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Squarepoint’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,724
Closed -$32K – 2854
2019
Q2 		$32K Sell
10,724
-3,376
-24% -$8.46K ﹤0.01% 2304
2019
Q1 		$25K Sell
14,100
-15,200
-52% -$21K ﹤0.01% 2091
2018
Q4 		$25K Sell
29,300
-223,600
-88% -$267K ﹤0.01% 1860
2018
Q3 		$359K Buy
252,900
+150,600
+147% +$165K ﹤0.01% 1456
2018
Q2 		$84K Buy
+102,300
New +$98.7K ﹤0.01% 1653

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Squarepoint's CVRS Position: Q3 2019 in Review

Squarepoint sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q3 2019, closing a stake of 10,724 shares — an estimated $32K sold.

Squarepoint first reported a position in CVRS in Q2 2018 and held it in 5 quarters. The position peaked at $359K in Q3 2018. 101 funds tracked by Wall St. Rank hold CVRS as of Q3 2019.

  • Squarepoint reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q3 2019 after selling out during the quarter.
  • Squarepoint sold 10,724 CORINDUS VASCULAR ROBOTICS, INC shares in Q3 2019, an estimated $32K.
  • Squarepoint first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2018 and held it in 5 quarters.
  • Squarepoint's CORINDUS VASCULAR ROBOTICS, INC position peaked at $359K in Q3 2018.
  • 101 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q3 2019.

Based on Squarepoint's 13F filing for Q3 2019, filed 14 Nov 2019.